Ticker Talk Icon with Horizontal Wordmark

Stay ahead of the markets.

Welcome to TickerTalk, where financial insights meet real-time relevance! Dive into a curated stream of breaking news, expert analyses, and exclusive market updates delivered straight to your inbox.

TickerTalk: Your Source for Real-Time Financial Insights and Breaking News

Newest Stories

Sarepta Therapeutics logo seen displayed on a smartphone with the stock market graphic in the background
Sarepta Therapeutics Stock Soars on FDA Approval

Sarepta Therapeutics (NASDAQ: SRPT) is leading the game in precision genetic medicine and biotechnology. Sarepta Therapeutics' stock price has witnessed a surge of over 40% after receiving expanded FDA approval for its Duchenne muscular dystrophy (DMD) gene therapy, Elevidys. This pivotal decisi...

Jeffrey Neal Johnson | Jun 21, 2024

CarMax: A Market Melt-Up Waiting to Happen for this Stock
CarMax: A Market Melt-Up Waiting to Happen for this Stock

CarMax (NYSE: KMX) is set up for a market melt-up because of improving market sentiment. The used car market is still struggling due to market normalization, but it is sufficient to drive solid cash flow for this business, and the trends are improving. The critical takeaway from the Q1 report is t...

Thomas Hughes | Jun 21, 2024

NextEra Energy stock buy or sell on smartphone screen
3 Solar Stocks to Watch that are Building the Green Energy Future

The renewable energy sector is experiencing unprecedented growth, a trend reflected in the record-breaking 2023 installation of 305 gigawatts (GW) of new solar capacity worldwide. This surge signifies a global shift towards cleaner energy sources, with solar and wind power playing a central role i...

Jeffrey Neal Johnson | Jun 21, 2024

Vials of liquid on a white table and the logo of Gilead Sciences
Gilead Sciences Stock Surges on HIV Treatment Trial Success

Gilead Sciences (NASDAQ: GILD) saw its stock jump nearly 10% yesterday after announcing groundbreaking results from its HIV treatment trial. The biopharmaceutical company revealed 100% efficacy in its Phase 3 HIV prevention trial, marking the first trial showing zero infections.  Given the s...

Ryan Hasson | Jun 21, 2024

TickerTalk Unveils Real-Time Financial Insights and Breaking News!